Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00633906 · ClinicalTrials.gov registry record · NA

HORIZONS HIV Intervention

A NA study, sponsored by Emory University.

Completed
Registry status
NA
Development phase
715
Enrollment target

NCT00633906: Completed NA study, sponsored by Emory University.

NCT00633906 is a NA study that has completed, run by Emory University. The registered enrollment target is 715 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (49% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00633906, a NA study, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
715 participants
Enrollment target

Study Summary

The Horizons Program will test the efficacy of a multi-session HIV prevention program for African American female teens attending reproductive health clinics in Atlanta, GA.

Interventions

  • BEHAVIORAL HORIZONS HIV Intervention
  • BEHAVIORAL enhanced standard-of-care

Trial Details

FieldValue
Enrollment Target 715 participants
Start Date 2002-04
Est. Completion 2005-10
Phase NA
Emory University

1,208 total trials

What the finished NCT00633906 record still lists

NCT00633906 is an interventional study that assigns participants to a tested intervention. The registered 715 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (49% lower).

The record links to 0 conditions, and to 2 interventions - of which HORIZONS HIV Intervention is the first listed.

NCT00633906 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00633906 about?

NCT00633906 is a clinical study titled "HORIZONS HIV Intervention". The Horizons Program will test the efficacy of a multi-session HIV prevention program for African American female teens attending reproductive health clinics in Atlanta, GA.

What is the current status of trial NCT00633906?

This trial is currently completed. It is a NA study. The enrollment target is 715 participants. The study started on 2002-04. Estimated completion is 2005-10.

What interventions are being tested in trial NCT00633906?

The interventions under investigation include: HORIZONS HIV Intervention (BEHAVIORAL), enhanced standard-of-care (BEHAVIORAL).

Who is sponsoring clinical trial NCT00633906?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00633906's enrollment target sits among peer trials

715 147th of 2000 higher than 1,854 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04680000 · 716 participants · NA

    Chronic Pain Management In Primary Care Using Behavioral Health Consultants

  • NCT05208762 · 714 participants · Phase 1

    A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

  • NCT06758401 · 714 participants · Phase 3

    This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  • NCT04916327 · 720 participants · NA

    Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00633906, the US trial registry maintained by the National Library of Medicine. NCT00633906 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.